FDA Inspection 1167937 — Oklahoma Lions Eye Bank
The FDA completed an inspection of Oklahoma Lions Eye Bank on Apr 13, 2022 in Oklahoma City, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 13, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Oklahoma City, OK (United States)